Cargando…

Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis

INTRODUCTION: Venous thromboembolism (VTE) is a life-threatening complication of anti-neutrophil cytoplasmic autoantibody (ANCA) vasculitis whose mechanism remains incompletely elucidated. We tested the hypothesis that elevated microparticle tissue factor activity (MPTFa) or anti-plasminogen antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendoza, Carmen E., Brant, Elizabeth J., McDermott, Matthew L., Froment, Anne, Hu, Yichun, Hogan, Susan L., Jennette, J. Charles, Falk, Ronald J., Nachman, Patrick H., Derebail, Vimal K., Bunch, Donna O’Dell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933462/ https://www.ncbi.nlm.nih.gov/pubmed/31891003 http://dx.doi.org/10.1016/j.ekir.2019.07.006

Ejemplares similares

Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis
por: Alba, Marco A., et al.
Publicado: (2022)

Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Hogan, Susan L., et al.
Publicado: (2019)

Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
por: Yang, Jiajin, et al.
Publicado: (2016)

Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis
por: Cao, Binxin, et al.
Publicado: (2023)

Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries
por: Huang, Shirley P, et al.
Publicado: (2022)

Association of Lupus Nephritis Histopathologic Classification With Venous Thromboembolism—Modification by Age at Biopsy
por: Cooley, Ian, et al.
Publicado: (2021)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
por: Michailidou, Despina, et al.
Publicado: (2022)

Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
por: Tran, John Chuan Nguyen, et al.
Publicado: (2022)

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Merkel, Peter A., et al.
Publicado: (2017)

High Basal Activity of the PTPN22 Gain-of-Function Variant Blunts Leukocyte Responsiveness Negatively Affecting IL-10 Production in ANCA Vasculitis
por: Cao, Yali, et al.
Publicado: (2012)

Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis
por: King, C., et al.
Publicado: (2022)

Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
por: Thoms, Brendan L., et al.
Publicado: (2021)

A rare cause of the pulmonary-renal syndrome: a case of atypical haemolytic-uraemic syndrome complicated by pulmonary haemorrhage
por: Derebail, Vimal K., et al.
Publicado: (2008)

Autoantibodies in vasculitis
por: Wiik, Allan
Publicado: (2003)

PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease
por: Chen, Dhruti P., et al.
Publicado: (2023)

Practice Patterns of Induction Therapy in Severe Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis
por: Aqeel, Faten, et al.
Publicado: (2022)

Venous thromboembolism in anti-neutrophil cytoplasmic antibody-associated vasculitis: an underlying prothrombotic condition?
por: Antovic, Aleksandra, et al.
Publicado: (2020)

Autoantibodies in Systemic Vasculitis
por: Silva de Souza, Alexandre Wagner
Publicado: (2015)

Looks can be Deceiving: A Challenging Case of Anti-Neutrophil Cytoplasmic Autoantibody Associated Vasculitis
por: Ramadan, Bashar, et al.
Publicado: (2021)

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2021)

Antineutrophil Cytoplasmic Autoantibody (ANCA)-Associated Vasculitis With Mucosal Involvement Following COVID-19 Pneumonia
por: Ta, Hoang, et al.
Publicado: (2022)

Repeat Kidney Biopsies in Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Clinical and Histologic Progression
por: Aqeel, Faten, et al.
Publicado: (2023)

Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy
por: Lee, Taewoo, et al.
Publicado: (2020)

Subarachnoid Hemorrhage in Autoimmune Vasculitis: A Rare Presentation of Systemic Lupus Erythematosus-Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis Overlap Syndrome
por: Palleti, Sujith K, et al.
Publicado: (2023)

Successful treatment for thrombotic thrombocytopenic purpura complicated with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis
por: Yamauchi, Yoko, et al.
Publicado: (2010)

Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Almaani, Salem, et al.
Publicado: (2023)

Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis
por: Zhao, Xiaohong, et al.
Publicado: (2020)

Clinicopathological Characteristics and Influencing Factors of Renal Vascular Lesions in Anti-neutrophil Cytoplasmic Autoantibody-Related Renal Vasculitis
por: Wang, Ruiqiang, et al.
Publicado: (2021)

Renal Expression of Annexin A1 Is Associated With the Severity of Renal Injury in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
por: Wang, Rui-Xue, et al.
Publicado: (2022)

Review of systemic sclerosis and antineutrophil cytoplasmic antibody vasculitis overlap: Using autoantibodies for a personalised medicine approach
por: Clark, Kristina EN
Publicado: (2022)

A Proposed Classification of the Immunological Diseases
por: McGonagle, Dennis, et al.
Publicado: (2006)

Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity
por: Lardinois, Olivier M., et al.
Publicado: (2019)

Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
por: van Leeuwen, Jolijn R., et al.
Publicado: (2022)

Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune System
por: Little, Mark A., et al.
Publicado: (2012)

Urinary Levels of High Mobility Group Box-1 Are Associated with Disease Activity in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
por: Ma, Tian-Tian, et al.
Publicado: (2015)

Contraceptive Use and Elective Terminations in Women Enrolled in the Glomerular Disease Collaborative Network
por: Reynolds, Monica L., et al.
Publicado: (2020)

Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus
por: Thom, Stephen R., et al.
Publicado: (2023)

The Authors Reply
por: Lee, Taewoo, et al.
Publicado: (2020)

Clinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center
por: Pu, Lei, et al.
Publicado: (2017)

Clinicopathological characteristics and outcomes of anti-neutrophil cytoplasmic autoantibody-related renal vasculitis with hyperuricemia: a retrospective case-control study
por: Wang, Ruiqiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9q8l3uen5io0ekb71gk1q25f38